MX2014002533A - Producto farmaceutico y metodo de analisis de exposicion a la luz de un producto farmaceutico. - Google Patents

Producto farmaceutico y metodo de analisis de exposicion a la luz de un producto farmaceutico.

Info

Publication number
MX2014002533A
MX2014002533A MX2014002533A MX2014002533A MX2014002533A MX 2014002533 A MX2014002533 A MX 2014002533A MX 2014002533 A MX2014002533 A MX 2014002533A MX 2014002533 A MX2014002533 A MX 2014002533A MX 2014002533 A MX2014002533 A MX 2014002533A
Authority
MX
Mexico
Prior art keywords
change
photosensitive
property
active ingredient
product according
Prior art date
Application number
MX2014002533A
Other languages
English (en)
Spanish (es)
Inventor
Jemery Guo
Deborah Shnek
Paula Spencer
Li Sun
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2014002533A publication Critical patent/MX2014002533A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • B65D79/02—Arrangements or devices for indicating incorrect storage or transport
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change

Landscapes

  • Mechanical Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Packages (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2014002533A 2011-09-02 2012-08-31 Producto farmaceutico y metodo de analisis de exposicion a la luz de un producto farmaceutico. MX2014002533A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161530824P 2011-09-02 2011-09-02
PCT/US2012/053450 WO2013033600A1 (en) 2011-09-02 2012-08-31 Pharmaceutical product and method of analysing light exposure of a pharmaceutical product

Publications (1)

Publication Number Publication Date
MX2014002533A true MX2014002533A (es) 2014-08-26

Family

ID=46982918

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014002533A MX2014002533A (es) 2011-09-02 2012-08-31 Producto farmaceutico y metodo de analisis de exposicion a la luz de un producto farmaceutico.

Country Status (13)

Country Link
US (1) US20140315187A1 (zh)
EP (1) EP2750989A1 (zh)
JP (1) JP2014529473A (zh)
KR (1) KR20140058669A (zh)
CN (1) CN103917458A (zh)
AU (1) AU2012301656A1 (zh)
BR (1) BR112014004591A2 (zh)
CA (1) CA2840637A1 (zh)
CL (1) CL2014000104A1 (zh)
EA (1) EA201490555A1 (zh)
MX (1) MX2014002533A (zh)
WO (1) WO2013033600A1 (zh)
ZA (1) ZA201309704B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202785A1 (en) 2015-06-17 2016-12-22 Novozymes A/S Container
IL250601B (en) * 2017-02-14 2018-05-31 Marpaz Tech Ltd Container for light sensitive material
WO2020172257A1 (en) * 2019-02-22 2020-08-27 The Chemours Company Fc, Llc Methods for determining photosensitive properties of a material

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3483106D1 (de) * 1983-02-25 1990-10-11 Lifelines Technology Inc Ueberwachungsverfahren fuer incrementale umgebungseinwirkungen auf produkte, erfassbar fuer fortschreitende qualitaetsaenderungen.
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (de) 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5962406A (en) 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
JPH06174600A (ja) * 1992-09-16 1994-06-24 Caterpillar Inc 状態変化を表示する方法および装置
PT672141E (pt) 1992-10-23 2003-09-30 Immunex Corp Metodos de preparacao de proteinas oligomericas soluveis
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
JP4435304B2 (ja) 1995-06-29 2010-03-17 イミュネックス・コーポレーション アポトーシスを誘導するサイトカイン
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001036637A1 (en) 1999-11-17 2001-05-25 Immunex Corporation Receptor activator of nf-kappa b
WO2001083525A2 (en) 2000-05-03 2001-11-08 Amgen Inc. Modified peptides, comprising an fc domain, as therapeutic agents

Also Published As

Publication number Publication date
CA2840637A1 (en) 2013-03-07
ZA201309704B (en) 2014-08-27
BR112014004591A2 (pt) 2017-03-28
AU2012301656A1 (en) 2014-01-16
EA201490555A1 (ru) 2014-07-30
US20140315187A1 (en) 2014-10-23
KR20140058669A (ko) 2014-05-14
CN103917458A (zh) 2014-07-09
EP2750989A1 (en) 2014-07-09
JP2014529473A (ja) 2014-11-13
CL2014000104A1 (es) 2014-07-25
WO2013033600A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
Lubiniecki et al. Comparability assessments of process and product changes made during development of two different monoclonal antibodies
Le Basle et al. Physicochemical stability of monoclonal antibodies: a review
Razinkov et al. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools
Vugmeyster et al. Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges
ES2349885T3 (es) Análisis de la citotoxicidad celular que depende de anticuerpos.
CN102695956B (zh) 用于检测对治疗性抗IgE抗体特异性的抗体的测定法及其在过敏反应中的用途
Shi et al. Recognition of human IgG1 by Fcγ receptors: structural insights from hydrogen–deuterium exchange and fast photochemical oxidation of proteins coupled with mass spectrometry
ES2905615T3 (es) Sistemas y métodos para evaluar moduladores de puntos de control inmunitario
MX2014002533A (es) Producto farmaceutico y metodo de analisis de exposicion a la luz de un producto farmaceutico.
Alam et al. Deamidation can compromise antibody colloidal stability and enhance aggregation in a pH-dependent manner
Prior et al. International standards for monoclonal antibodies to support pre-and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
CN103619877B (zh) 修饰的可变结构域分子及其产生和使用方法b
Kagdi et al. Determination of holdup volume and transient contact compatibility of closed system transfer devices for a reconstituted lyophilized drug product
Schreiber et al. Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
CN117110492A (zh) 鉴别蛋白质中的游离巯基的方法
Gürel et al. Optimized methods for analytical and functional comparison of biosimilar mAb drugs: A case study for Avastin, Mvasi, and Zirabev
Hambly et al. Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studies
Gurel et al. Structural and functional analysis of CEX fractions collected from a novel avastin® biosimilar candidate and its innovator: a comparative study
US20170285023A1 (en) Portable Devices for Detection of Antibodies Against Therapeutic Drugs
US20190079100A1 (en) Methods of glycoprotein analysis
CN112041341B (zh) Ccl14的抗体和检测
CA2999866C (en) Composition and methods for assessing sensitivity and specificity of antibody detection reagents
IL294765B2 (en) Deglycosylation methods for electrophoresis of glycosylated proteins
Mazzeo et al. Stability studies for biologics
EP3864410A1 (en) Methods and systems for determining synapse formation